The nation’s supply of the widely used Cancer drug cisplatin has almost returned to pre-shortage levels. (Becker’s Hospital Review)

The FDA announced a new and updated indication for temozolomide (Temodar) in anaplastic astrocytoma.

Reality-TV celebrity Teddi Mellencamp, daughter of musician John Mellencamp, revealed that she has had “11 or 12” melanoma lesions in recent years. (NBC News)

Living in areas with high levels of particulate air pollution was associated with an increased risk of Breast Cancer. (Journal of the National Cancer Institute)

Testing for tumor DNA in Breast milk might represent a liquid biopsy for early diagnosis of breast cancer during pregnancy or the postpartum period. (Vall d’Hebron Institute of Oncology, Cancer Discovery)

A group of independent oncologists sued Jefferson Health, alleging the health system violated federal antitrust and kickback laws with a “concerted campaign to eliminate” the group’s “presence in the oncology marketplace.” (STAT)

The HHS Office of Research Integrity concluded that two cancer researchers who formerly worked at Weill Cornell Medicine in New York City engaged in research misconduct by publishing fake data in a dozen since-retracted journal articles. (Retraction Watch)

Health policy researchers called on the FDA to strengthen the agency’s accelerated approval program by requiring randomized controlled trials as the “preferred approach” to support accelerated approval of cancer drugs. (Regulatory Focus, New England Journal of Medicine)

Estrogen receptor-positive breast cancer has different metabolic profiles in Black and white women, a potential clue to the higher rate of aggressive disease and higher breast cancer mortality among Black patients. (University of Illinois, Nature Scientific Reports)

More than 70% of women mistakenly believe that an annual Pap smear includes testing for ovarian cancer, according to a survey by Myriad Genetics.